Subsidy Tracker Parent Company Summary

Parent Company Name: 
Pfizer
Ownership Structure: 
publicly traded (ticker symbol PFE)
Headquartered in: 
New York
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Subsidy SummarySubsidy ValueNumber of Awards
State/Local$321,126,648188
Federal (grants and allocated tax credits)$54,408,69829
TOTAL$375,535,346217
Loan / Bailout SummaryTotal Face ValueNumber of Awards
State/Local loans, bond financing and venture capital$220,000,0001
Federal loans, loan guarantees and bailout assistance (not including repayments)$00
TOTAL$220,000,0001
Time Period for State and Local Awards: 

Earliest year of data: 1992. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2009.

Time Period for Federal Awards: 

FY2000 to the present

Notes: 

Dollar totals do not include awards for which no subsidy value is disclosed.

Associated Names: 

ALPHARMA SPECIALTY PHARMA; AMERICAN HOME PROD; ANACOR PHARMACEUTICALS; BIOREXIS; DORAL / PFIZER; EMBREX; FOLDRX PHARMACEUTICALS; GD SEARLE; HOSPIRA; ICAGEN; INNOPHARMA; KING PHARMACEUTICALS LLC; KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT; PARKE DAVIS; PARKEDALE PHARMACEUTICALS; PFIZER; PFIZER HOLDING AMERICAS; PHARMACIA; SERENEX; UPJOHN; WARNER LAMBERT; WYETH

Links: 

For a summary of this company's regulatory violations see its Violation Tracker summary page here.

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.

For a summary of this company's federal contracts, see its page on Fedspending.

For an overview of political contributions associated with this company, see its Follow the Money page.


Top 5 States for state/local awardsTotal Subsidy $Number of Awards
Michigan$85,200,0002
Connecticut$60,000,0001
North Carolina$49,205,26974
New York$44,472,07926
New Jersey$38,807,8315
All other$43,441,46980

Individual Subsidy Records:

Click on the company name for more information on each subsidy award.
Download results as CSV or XML
Company Location Subsidy Source Year Subsidy Value Loan/Bailout Value Type of Subsidysort icon
Pfizer, Inc. North Carolina state 2011 $501,793 tax credit/rebate
Alpharma Specialty Pharma, Inc. North Carolina state 2012 $3,885 tax credit/rebate
Embrex, Inc. North Carolina state 2012 $32,718 tax credit/rebate
Icagen, Inc. North Carolina state 2012 $54,345 tax credit/rebate
Wyeth Holdings Corporation North Carolina state 2012 $218,644 tax credit/rebate
Pfizer, Inc. North Carolina state 2012 $607,213 tax credit/rebate
Alpharma, Inc. West Virginia state 2007 undisclosed tax credit/rebate
Pfizer Inc. & Subsidiaries Maryland state 2010 $18,433 tax credit/rebate
Pfizer Inc. & Subsidiaries Maryland state 2011 $49,888 tax credit/rebate
Pfizer, Inc. Maryland state 2008 $131,514 tax credit/rebate
Pfizer Corporation Maryland state 2007 $123,426 tax credit/rebate
Pharmacia Corporation Maryland state 2008 $74,621 tax credit/rebate
Pfizer Inc. & Subsidiaries Maryland state 2012 $60,651 tax credit/rebate
Pfizer Inc. Maryland state 2005 $60,097 tax credit/rebate
Pfizer, Inc. Maryland state 2009 $56,291 tax credit/rebate
Pfizer Inc. Maryland state 2004 $33,734 tax credit/rebate
Pharmacia Corporation Maryland state 2007 $9,773 tax credit/rebate
Pharmacia Corporation Maryland state 2005 $4,398 tax credit/rebate
Pharmacia Corporation Maryland state 2004 $1,884 tax credit/rebate
Pfizer Inc. & Subsidiaries Maryland state 2014 $60,651 tax credit/rebate
Pfizer, Inc. North Carolina state 2013 $755,362 tax credit/rebate
Wyeth Holdings Corporation North Carolina state 2013 $272,967 tax credit/rebate
Pharmacia Corporation North Carolina state 2013 $145,378 tax credit/rebate
Embrex, Inc. North Carolina state 2013 $31,549 tax credit/rebate
Icagen, Inc. North Carolina state 2013 $29,917 tax credit/rebate
Wyeth Pharmaceuticals, Inc. North Carolina state 2013 $1,058 tax credit/rebate
Hospira, Inc. North Carolina state 2013 $261,281 tax credit/rebate
Wyeth Holdings Corporation North Carolina state 2013 $4,097,786 tax credit/rebate
Hospira, Inc. North Carolina state 2013 $231,735 tax credit/rebate
Wyeth Holdings Corporation North Carolina state 2014 $3,476,438 tax credit/rebate
Hospira, Inc. North Carolina state 2014 $59,897 tax credit/rebate
Embrex, Inc. North Carolina state 2014 $5,969 tax credit/rebate
Wyeth Holdings Corporation North Carolina state 2014 $143,193 tax credit/rebate
Wyeth Pharmaceuticals, Inc. North Carolina state 2013 $1,058 tax credit/rebate
Icagen, Inc. North Carolina state 2013 $29,917 tax credit/rebate
Embrex, Inc. North Carolina state 2013 $31,549 tax credit/rebate
Pharmacia Corporation North Carolina state 2013 $145,378 tax credit/rebate
Wyeth Holdings Corporation North Carolina state 2013 $272,967 tax credit/rebate
Pfizer, Inc. North Carolina state 2013 $755,362 tax credit/rebate
Alpharma Specialty Pharma, Inc. North Carolina state 2012 $3,885 tax credit/rebate
Embrex, Inc. North Carolina state 2012 $32,718 tax credit/rebate
Icagen, Inc. North Carolina state 2012 $54,345 tax credit/rebate
Wyeth Holdings Corporation North Carolina state 2012 $218,644 tax credit/rebate
Pfizer, Inc. North Carolina state 2012 $607,213 tax credit/rebate
Hospira, Inc. North Carolina state 2014 $218,428 tax credit/rebate
Wyeth Holdings Corporation North Carolina state 2014 $143,193 tax credit/rebate
Embrex, Inc. North Carolina state 2014 $5,969 tax credit/rebate
Doral/Pfizer New York local 2014 $607,052 tax credit/rebate
Wyeth Pharmaceuticals, Inc. North Carolina state 2016 $3,214 tax credit/rebate
Wyeth Pharmaceuticals, Inc. North Carolina state 2015 $3,442 tax credit/rebate
King Pharmaceuticals Research and Development, Inc. North Carolina state 2016 $3,809 tax credit/rebate
King Pharmaceuticals Research and Development, Inc North Carolina state 2015 $15,133 tax credit/rebate
Embrex, Inc. North Carolina state 2016 $16,007 tax credit/rebate
Hospira, Inc. North Carolina state 2016 $25,455 tax credit/rebate
Icagen, Inc. North Carolina state 2016 $26,647 tax credit/rebate
Icagen, Inc. North Carolina state 2015 $60,444 tax credit/rebate
Embrex, Inc. North Carolina state 2015 $61,459 tax credit/rebate
Pfizer Holdings Americas Corporation North Carolina state 2016 $66,776 tax credit/rebate
Pfizer Holdings Americas Corporation North Carolina state 2015 $187,566 tax credit/rebate
Pfizer Holdings Americas Corporation North Carolina state 2015 $236,159 tax credit/rebate
Hospira, Inc. North Carolina state 2015 $240,137 tax credit/rebate
Hospira, Inc. North Carolina state 2016 $277,903 tax credit/rebate
Hospira, Inc. North Carolina state 2016 $415,010 tax credit/rebate
Hospira, Inc. North Carolina state 2015 $623,585 tax credit/rebate
Pfizer, Inc. North Carolina state 2016 $1,013,383 tax credit/rebate
Pfizer, Inc. North Carolina state 2015 $1,320,134 tax credit/rebate
Doral/Pfizer New York local 2015 $402,469 tax credit/rebate
Pfizer Inc., and Subsidiaries Maryland state 2015 $427,891 tax credit/rebate
Pfizer, Inc. & Subsidiaries Maryland state 2016 $79,533 tax credit/rebate
Pfizer, Inc. Pennsylvania state 2016 $237,427 tax credit/rebate
Doral/Pfizer New York local 2016 $402,469 tax credit/rebate
Pfizer Inc. & Subsidiaries Maryland state 2017 $183,559 tax credit/rebate
Pfizer, Inc. Michigan state 2019 $1,000,000 tax credit/rebate
Doral/Pfizer New York local 2003 $613,020 tax credit/rebate; property tax abatement
Doral Arrowwood (Pfizer) New York local 2004 $3,137,110 tax credit/rebate; property tax abatement
Pfizer, Inc. New York local 2004 $1,919,713 tax credit/rebate; property tax abatement
Pfizer, Inc. New York local 2005 $3,276,473 tax credit/rebate; property tax abatement
Doral Arrowwood (Pfizer) New York local 2005 $701,075 tax credit/rebate; property tax abatement
Pfizer, Inc. New York local 2006 $3,750,210 tax credit/rebate; property tax abatement
Doral Arrowwood (Pfizer) New York local 2006 $2,022,893 tax credit/rebate; property tax abatement
Pfizer, Inc. New York local 2007 $5,510,432 tax credit/rebate; property tax abatement
Doral/Pfizer New York local 2007 $662,163 tax credit/rebate; property tax abatement
Doral/Pfizer New York local 2009 $932,710 tax credit/rebate; property tax abatement
WYETH HOLDINGS CORPORATION New York local 2009 $280,900 tax credit/rebate; property tax abatement
Pfizer New York local 2003 $10,401,000 tax credit/rebate; property tax abatement
Doral/Pfizer New York local 2010 $596,605 tax credit/rebate; property tax abatement
Pfizer, Inc. New York local 2008 $862,541 tax credit/rebate; property tax abatement
Doral/Pfizer New York local 2008 $462,392 tax credit/rebate; property tax abatement
Doral/Pfizer New York local 2011 $360,540 tax credit/rebate; property tax abatement
Doral/Pfizer New York local 2012 $357,613 tax credit/rebate; property tax abatement
Doral/Pfizer New York local 2013 $516,004 tax credit/rebate; property tax abatement
HOSPIRA, INC. California state 2006 $439,595 training reimbursement
HOSPIRA, INC. California state 2009 $536,590 training reimbursement
Hospira, Inc California state 2007 undisclosed training reimbursement
PFIZER, INC. Missouri state 2007 $2,000,000 training reimbursement
BioRexis Pennsylvania state $250,000 training reimbursement
Hospira, Inc. Kansas state 2006 $68,770 training reimbursement
Hospira, Inc. Kansas state 2007 $190,000 training reimbursement
Hospira Inc. Colorado state 2014 $31,104 training reimbursement
Download results as CSV or XML